Pharmaceutical Contract Manufacturing Market By Application: API Production, Formulation Development, By End-Use: Pharmaceutical Companies, Biotech Companies, By Region: North America, Europe, Asia Pacific, Segment Forecasts: 2024 - 2030
Pharmaceutical Contract Manufacturing Market Trends
The pharmaceutical contract manufacturing market was valued at USD 132.5 billion in 2024 and is projected to grow at a CAGR of 7.6% from 2025 to 2030. Outsourcing manufacturing processes is becoming increasingly common among pharmaceutical and biotech companies.
Product Insights
API production applications represented the largest market segment in 2024, accounting for 58.4% of total revenue. Formulation development is also gaining traction as companies seek to enhance product efficacy and safety.
End-Use Insights
Pharmaceutical companies were the largest end-users in 2024, holding a 68.9% market share, as they leverage contract manufacturing to streamline operations and focus on core competencies. Biotech companies are also increasingly utilizing these services to bring innovative products to market.
Regional Insights
North America dominated the pharmaceutical contract manufacturing market with a 46.8% share in 2024, supported by a robust pharmaceutical industry and high demand for contract services. The Asia Pacific region is expected to experience steady growth, driven by cost advantages and increasing manufacturing capabilities.
GET A FREE SAMPLE
This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.